Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthermic isolated limb perfusion for extremity sarcomas.

C J Kim1, C Puleo, G D Letson

  • 1Cultaneous Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla. 33612-9497, USA.

Cancer Control : Journal of the Moffitt Cancer Center
|May 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amsterdam Placental Workshop Group Consensus Statement definitions revisited: Basal chronic villitis.

Virchows Archiv : an international journal of pathology·2025
Same author

Investigation of liver-targeted peripheral focused ultrasound stimulation (pFUS) and its effect on glucose homeostasis and insulin resistance in type 2 diabetes mellitus: a proof of concept, phase 1 trial.

QJM : monthly journal of the Association of Physicians·2023
Same author

Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy.

BJA education·2023
Same author

Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias.

BJA education·2023
Same author

Risk Factors that Predict Levothyroxine Medication after Thyroid Lobectomy.

Acta endocrinologica (Bucharest, Romania : 2005)·2021
Same author

Antimicrobial therapy during cancer treatment: Beyond antibacterial effects.

Journal of internal medicine·2020

Hyperthermic isolated limb perfusion (HILP) offers a promising treatment for unresectable extremity sarcomas, successfully salvaging limbs in most patients. This limb-sparing approach helps preserve function and quality of life.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Physics

Background:

  • Extremity sarcomas present limited treatment options, often involving amputation or limb-sparing surgery with radiation, leading to significant morbidity.
  • Hyperthermic isolated limb perfusion (HILP) emerges as a potential alternative for unresectable lesions, aiming to preserve limb function and enhance patient quality of life.

Purpose of the Study:

  • To evaluate the outcomes of Hyperthermic Isolated Limb Perfusion (HILP) in patients with unresectable primary or recurrent extremity sarcomas.
  • To assess the efficacy and safety of HILP as a limb-sparing treatment modality.

Main Methods:

  • Retrospective analysis of 5 patients with unresectable extremity sarcomas treated with HILP between 1994 and 2000.
  • Inclusion criteria: primary or recurrent unresectable extremity sarcomas.

Related Experiment Videos

Main Results:

  • All patients achieved complete initial clinical responses following HILP.
  • Limb salvage was successful in 4 out of 5 patients (80%).
  • Complications observed included chronic lymphedema, neuropathic pain, and delayed wound healing.

Conclusions:

  • Hyperthermic isolated limb perfusion (HILP) with melphalan is a safe and effective treatment for selected patients with locally advanced, unresectable extremity sarcomas.
  • High response rates and successful limb salvage rates suggest HILP's value in managing these challenging cases.
  • Further investigation with larger patient cohorts is recommended to solidify these findings.